UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 7, 2006
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in charter)
|
|
|
|
|
Delaware
|
|
000-32883
|
|
13-4088127 |
(State or Other Jurisdiction
|
|
(Commission
|
|
(IRS Employer |
of Incorporation)
|
|
File Number)
|
|
Identification No.) |
|
|
|
5677 Airline Road,
|
|
|
Arlington, Tennessee
|
|
38002 |
(Address of Principal Executive Offices)
|
|
(Zip Code) |
Registrants telephone number, including area code: (901) 867-9971
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 1.01 . Entry into a Material Definitive Agreement.
As previously disclosed, the Board of Directors of Wright Medical Group, Inc. (the Company)
adopted the Wright Medical Group, Inc. Executive Performance Incentive Plan (the Plan) in 2005.
All officers of the Company, including executive officers, are eligible to participate in the Plan
and to receive bonus awards, if any, payable thereunder. The Plan is administered by the
Compensation Committee of the Board of Directors (the Committee). On February 7, 2006, the
Committee authorized the discretionary payment of bonuses for 2005 under the Plan to the Companys
15 officers together totaling approximately $395,000. On the same date, the Committee
determined that for 2006, and until otherwise changed, the funding of the bonus pool under the Plan
will be based upon the Companys performance compared to targets for operating income excluding
non-cash stock based compensation recorded pursuant to FASB Statement No. 123(R).
2